Federal Trade Commission v. Actavis, Inc. and Reverse-Payment or Pay-for-Delay Settlements
Nature Biotechnology, Vol. 31, p. 316, 2013
2 Pages Posted: 20 Jul 2013 Last revised: 26 Feb 2014
Date Written: April 1, 2013
An imminent US Supreme Court ruling should resolve one of the thorniest legal issues facing pharmaceutical companies today.
Keywords: antitrust, patent, intellectual property, settlement, pharmaceutical, biotechnology
JEL Classification: K00, K11, K1, K41, O34, O38
Suggested Citation: Suggested Citation